David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer about the REDUCE-IT and STRENGTH studies, which evaluated two kinds of omega-3 fatty acids – Vascepa and Epanova – for cardiac benefits.